Skip to content

Insider · CIK 0001379222

Nancy J Hutson

director

Files at BCRX (BIOCRYST PHARMACEUTICALS INC). First filing Dec 16, 2024, latest Dec 16, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $53k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BCRX: BIOCRYST PHARMACEUTICALS INC

BCRXOct 9, 2026 · close 8.55

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
2Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
$53k
7,000 shares
-7%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 13, 2024BCRX
BIOCRYST PHARMACEUTICALS INC
SOpen-market sale
Common Stock10b5-1
-7,000$7.54$53k86,638Dec 16, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nancy J Hutson: insider trades and track record | InsiderTell